Related Experiment Video
Updated: Jun 3, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Emerging immunosuppressive drugs in kidney transplantation
Christoph Metalidis1, Dirk R J Kuypers
1Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Belgium.
Current Clinical Pharmacology
|April 8, 2011
Summary
New immunosuppressive drugs aim to reduce side effects like cardiovascular issues and kidney damage seen with calcineurin inhibitors (CNI). These novel therapies target T-cell or antibody-mediated rejection for improved transplant outcomes.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Calcineurin inhibitors (CNI) are standard immunosuppressants but cause significant cardiovascular and oncogenic side effects.
- CNI-induced nephrotoxicity is a major factor in chronic allograft dysfunction and kidney transplant failure.
Purpose of the Study:
- To review novel immunosuppressive drugs with different mechanisms of action.
- To focus on agents balancing efficacy with reduced toxicity.
- To discuss drugs targeting T-cell or antibody-mediated rejection.
Main Methods:
- Review of current literature on new immunosuppressive agents.
- Analysis of mechanisms of action.
- Examination of pharmacokinetic data.
- Summary of preliminary clinical trial results.
Main Results:
- Novel immunosuppressants demonstrate potential for improved efficacy and safety profiles.
- These agents offer alternative strategies to CNI, addressing specific rejection pathways.
- Early clinical data suggest promise in managing transplant recipients.
Conclusions:
- New immunosuppressive drugs represent a promising advancement in transplantation.
- They offer alternatives to CNI, potentially mitigating adverse effects and improving long-term graft survival.
- Further research and clinical trials are essential to fully establish their role.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:40Cell-mediated Immune Responses
Overview
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...